Global Nasal Decolonization
Market Report
2024
Nasal Decolonization Market size will be USD 115.2 million in 2024 and will expand at a compound annual growth rate (CAGR) of 7.50% from 2024 to 2031.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Nasal Decolonization Market Report 2024.
According to Cognitive Market Research, the global nasal decolonization market size will be USD 115.2 million in 2024 and will expand at a compound annual growth rate (CAGR) of 7.50% from 2024 to 2031.
Base Year | 2023 |
Historical Data Time Period | 2019-2023 |
Forecast Period | 2024-2031 |
Global Nasal Decolonization Market Sales Revenue 2024 | $ 115.2 Million |
Global Nasal Decolonization Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.5% |
North America Nasal Decolonization Market Sales Revenue 2024 | $ 46.08 Million |
North America Nasal Decolonization Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.7% |
Europe Nasal Decolonization Market Sales Revenue 2024 | $ 34.56 Million |
Europe Nasal Decolonization Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6% |
Asia Pacific Nasal Decolonization Market Sales Revenue 2024 | $ 26.5 Million |
Asia Pacific Nasal Decolonization Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9.5% |
South America Nasal Decolonization Market Sales Revenue 2024 | $ 5.76 Million |
South America Nasal Decolonization Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6.9% |
Middle East and Africa Nasal Decolonization Market Sales Revenue 2024 | $ 2.3 Million |
Middle East and Africa Nasal Decolonization Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.2% |
Market Split by Type |
|
Market Split by Application |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Nasal Decolonization industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Nasal Decolonization Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Nasal decolonization is a potential but underutilized possibility that manages the illness. Another name for it is "nose decolonization." For evidence-based patients, lowering the risk of infection from different viruses during surgery is a safe strategy. Viral and common cold diseases cause the majority of reported sinus cases. Depending on how severe the infection is, these infections have been divided into acute and chronic categories.
Acute sinus infections heal after 30 days, whereas chronic infections persist for more than 90 days. When this infection first appears, it is easily recognized through physical examination based on features such as the anatomy of the nasal septum, the presence of polyps, and the nasal mucosa. MRI, CT, or ultrasound scans might also be necessary in order to treat this infection. Corticosteroids, antibiotics, sulfonamides, analgesics, and antihistamines are common medications used to treat sinus problems. The most often prescribed medications for the treatment of nasal decontamination are prednisone, mometasone, fluticasone, and triamcinolone.
Treatment for acute sinusitis in adults needs to be reevaluated increasingly. In many nations, drug-resistant bacteria are posing a major threat to public health, which has led to an overuse of antibiotics. This leads to higher rates of illness, mortality, and costs for individuals and healthcare systems. In order to provide patients with better alternative methods of treating their symptoms, companies in the sinus or nasal decolonization treatment industry are increasing their R&D spending. This is expected to propel the growth of the nasal decolonization market. Antibiotics are predicted to lead all therapeutic categories in the second-largest rise. However, most recent studies examining the efficacy of antibiotics for acute sinus infections have not included individuals with severe conditions or co-occurring conditions such as diabetes, pulmonary disorders, and other such issues and instead have recruited generally healthy adults.
The increase in the number of elderly patients with chronic rhinosinusitis with nasal polyps (CRSwNP), the quick uptake of minimally invasive surgeries by otorhinolaryngology surgeons, and the wealth of treatment options for nasal polyps coupled with growing research activities are anticipated to fuel the growth of the nasal decolonization market. The high expense of sinus surgery and issues including severe bleeding, leakage of cerebrospinal fluid, blurred vision, scars after surgery, and inflammation prevent the market from growing. Respiratory infections are more common in older adults who have respiratory issues. Although nasal decontamination can aid in lowering this risk, certain treatments on the market may not be appropriate for this purpose. In hospitals and senior care institutions, encouraging nasal decontamination as a preventive step can greatly minimize the spread of infections, reducing medical expenses and improving patient outcomes.
A kit called nasal decolonization is used as an antiseptic to prepare the skin. It aids in the reduction of bacterial growth that could lead to the patient's skin illnesses. In order to protect the nasal cavity before surgery, a broad-spectrum nasal decolonization kit is utilized to prepare the skin. It may be kept at room temperature and is designed for usage in hospitals and professional settings. Due to its ease of storage, the industry has adopted it widely. The healthcare sector uses it extensively to prevent patient infections. Additionally, it lowers the bacterial load and lowers the chance of illness in both patients and employees.
Without a prescription, using a nasal decontamination kit can cause a number of problems—this bundle. In the projected future, these factors are expected to hinder the growth of the nasal decolonization market. Furthermore, steroid medication's adverse effects, such as weight gain, a decrease in bone mineral density, and the onset of ocular cataracts, restrict market growth. Products for nasal decolonization may potentially cause certain unfavorable effects. The individual product being used will determine which side effects are experienced. Still, common ones include headaches, dryness or irritation of the nasal passages, burning or stinging in the nose, and nosebleeds. Prior to utilizing a nasal decolonization solution, it is crucial to be informed of these side effects, which are typically minor and transient.
The COVID-19 pandemic has been unprecedented and overwhelming on a global scale. Demand for nasal decolonization has exceeded expectations in every region when compared to pre-pandemic levels. When the pandemic ends, demand will likely recover to pre-pandemic levels, which explains the abrupt spike in CAGR.
The global frequency of COVID-19 patients and an increase in chronic illness cases are driving market growth. Making the most use of the medical infrastructure became a primary priority for governments worldwide during the COVID-19 epidemic. Due to the suspicion that cold, cough, and nasal decontamination were signs of COVID-19, the public was more aware of these symptoms. The kit became more and more in demand at different hospitals, assisted living homes, and other establishments. The pandemic forced the market for sinus therapeutic pharmaceuticals to increase the manufacture of medications intended to treat respiratory conditions.
We have various report editions of Nasal Decolonization Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Key players deploy strategic initiatives such as product innovations, partnerships, and mergers. Companies prioritize R&D to introduce cutting-edge products, ensuring a competitive edge. Robust distribution networks and adherence to quality standards amplify market presence, fostering an environment where agility and innovation define industry leaders.
In 2020, GlaxoSmithKline (GSK) and Medtronic plc entered into a co-promotion agreement for Mupirocin Ointment, a nasal decolonization product.
(Source: https://www.gsk.com/media/7854/our-code-of-practice.pdf)
Top Companies Market Share in Nasal Decolonization Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. The growing public consciousness regarding hospital-acquired infections (HAIs) and the significance of prophylactic actions is driving the application of nasal decontamination methods. The aging population in North America has compromised immune systems, making them more vulnerable to illnesses. As a result, there is a greater possible patient base for nasal decontamination treatments.
The Asia Pacific region is witnessing an increase in sales. A large portion of the nasal decolonization market share is anticipated to be held by Asia Pacific due to the region's expanding healthcare infrastructure. Furthermore, the increasing frequency of sinus infections can present a chance for the industry to expand.
The current report Scope analyzes Nasal Decolonization Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
According to Cognitive Market Research, the global Nasal decolonization market size was estimated at USD 115.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 46.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031. In North America, healthcare and preventative measures are highly prioritized. The use of nasal decolonization to lower the risk of hospital-acquired infections (HAIs) is increasing along with public awareness of these illnesses. North America's aging population makes them more vulnerable to surgical complications and respiratory problems. For this group, nasal decontamination provides a prophylactic measure. Healthcare systems incur high costs due to HAIs. Although nasal decolonization is a preventive measure, lowering infection rates can ultimately save hospital costs. There is continuing research into better nasal decontamination agents. This encourages creativity and could lead to more successful solutions in the future.
According to Cognitive Market Research, with a market value of USD 115.2 million in 2024, it is projected to expand at a compound annual growth rate (CAGR) of 6.0% from 2024 to 2031. Europe accounted for a share of over 30% of the global market size of USD 34.56 million. Since HAIs are a major cause of death and higher healthcare expenses in Europe, they are a big issue. Reducing the risk of HAIs, especially those brought on by vancomycin-resistant Enterococcus (VRE) and Staphylococcus aureus (MRSA), can be accomplished through nasal decolonization. Antibiotic-resistant microorganisms have emerged as a result of antibiotic misuse. A non-antibiotic method for lessening the load of these resistant microorganisms is nasal decontamination. Antimicrobial resistance is becoming more and more important, and European governments are putting laws in place to encourage the use of non-antibiotic therapies such as nasal decontamination. Europe's aging population makes them more vulnerable to HAIs. As a preventive step, this trend is anticipated to fuel demand for nasal decontamination solutions.
According to Cognitive Market Research, the global Nasal decolonization market size was estimated at USD 115.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 26.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2031. Healthcare facilities around the world are very concerned about HAIs, and Asia Pacific is no different. Nasal decolonization is one of the infection prevention strategies that are becoming more and more popular due to the rising incidence of HAIs. One of the biggest obstacles in the fight against illnesses is the rise of germs that are resistant to antibiotics. Through their removal from the nasal cavity, nasal decolonization can aid in limiting the spread of these germs. Asia Pacific's healthcare spending is expanding quickly as a result of aging populations and increased disposable incomes, among other reasons. As a result, more money is being spent on innovative medical procedures and technology, such as nasal decontamination kits.
According to Cognitive Market Research, the global Nasal decolonization market size was estimated at USD 115.2 Million, out of which the Latin America market has more than 5% of the global revenue with a market size of USD 5.76 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.9% from 2024 to 2031. Like many other regions, Latin America is also very concerned about HAIs. Because nasal decolonization can lower the incidence of HAIs, healthcare practitioners are becoming more aware of and utilizing these solutions. A different strategy for preventing infections is nasal decontamination, which is becoming increasingly important as antibiotic resistance spreads around the world. In Latin America, there is anticipated to be a rise in demand for nasal decolonization solutions as awareness of antibiotic resistance rises.
According to Cognitive Market Research, the global Nasal decolonization market size was estimated at USD 115.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 2.30 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031. Worldwide, healthcare facilities are very concerned about healthcare-associated infections (HAIs), and nasal carriage of Staphylococcus aureus (MRSA) is a prominent risk factor for these infections. The MEA region's need for nasal decontamination products will increase in tandem with the growing awareness of HAIs. The MEA region's governments are putting more and more emphasis on lowering HAIs and raising the standard of healthcare. Investment in infection control strategies, such as nasal decontamination, is rising as a result of this. In the MEA region, the use of cutting-edge technologies in the healthcare industry is becoming more and more popular. This involves applying novel nasal decolonization treatments, including povidone-iodine nasal solution and mupirocin nasal ointment.
Global Nasal Decolonization Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Nasal Decolonization Industry growth. Nasal Decolonization market has been segmented with the help of its Type, Application , and others. Nasal Decolonization market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
According to Cognitive Market Research, nasal mupirocin held the major market share over the forecast period. A typical drug used in nasal decolonization is mupirocin, a topical antibiotic marketed under the brands Centany and Bactroban. It works very well against MRSA, a common cause of healthcare-associated infections. Antibiotic-resistant bacteria have emerged as a result of antibiotic misuse, and they are getting harder to cure. Compared to systemic antibiotics, topical antibiotics like mugirocin are less prone to cause resistance.
Nasal povidone-iodine is the fastest-growing category over the forecast period. It has been demonstrated that the broad-spectrum antiseptic povidone-iodine (PVP-I) is useful in lowering the amount of S. aureus in the nose. There are several formulations of PVP-I available, such as nasal swabs and sprays. Healthcare providers or patients themselves can give these simple-to-use formulations.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Nasal Decolonization Industry. Request a Free Sample PDF!
According to Cognitive Market Research, hospitals hold a prominent market share. In an effort to lower the incidence of HAIs, hospitals are implementing nasal decolonization programs more frequently. Patients enrolled in these programs are usually screened for S. aureus colonization and subsequently treated with nasal decolonization products if colonized.
Retail pharmacy is the fastest-growing category over the forecast period. Patients can easily and conveniently get nasal decolonization products from retail pharmacies. Pharmacies usually have more flexible hours and lower wait times than hospitals. The market for nasal decontamination is expanding, and this will be advantageous for the retail pharmacy channel. Pharmacies can significantly contribute to the decrease of HAIs by informing patients about the advantages of these products and providing easy access.
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Nasal Decolonization market report 2024 Edition by contacting our team.
Research Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses
I played a pivotal role in conducting market research and competitive analysis. I have a demonstrated ability to synthesize diverse data sources, identify trends, and translate findings into actionable recommendations. My collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization. I am committed to maintaining excellence through continuous learning and staying ahead of industry trends. Regular participation in conferences and professional development opportunities keeps my skills sharp and relevant.
Disclaimer:
Type | Nasal Mupirocin , Nasal Povidone Iodine , Other |
Application | Hospital , Retail Pharmacy , Other |
List of Competitors | Global Life Technologies, PDI Healthcare, 3M, Clorox Healthcare, Medline, GSK, Teva, Glenmark Pharms, SmithKline & French, Taro Pharmaceutical, Perrigo |
This chapter will help you gain GLOBAL Market Analysis of Nasal Decolonization. Further deep in this chapter, you will be able to review Global Nasal Decolonization Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
Chapter 2 North America Market Analysis
Purchase Add-Ons to Customize the Report Edition and get further granular data level data about the North America market. Add-On Cost: Request before placing the order, Respective Pricing will be informed after sending the inquiry
Qualitative Analysis for the North America Market: North America Nasal Decolonization Market Trends North America Nasal Decolonization Technological Road Map North America Nasal Decolonization Market Drivers North America Nasal Decolonization Market Restraints North America Nasal Decolonization Market Opportunity Market Attractiveness Analysis COVID – 19 Impact Analysis PESTEL Analysis Porter’s Five Forces Analysis Product Life Cycle Industrial Chain Analysis
You can purchase only the Executive Summary North America Market (2019 vs 2024 vs 2031)
Chapter 3 Europe Market Analysis
You can purchase only the Executive Summary Europe Market (2019 vs 2024 vs 2031)
Chapter 4 Asia-Pacific Market Analysis
You can purchase only the Executive Summary Asia Pacific Market (2019 vs 2024 vs 2031)
Chapter 5 South America Market Analysis
You can purchase only the Executive Summary South America Market (2019 vs 2024 vs 2031)
Chapter 6 Middle East and Africa Market Analysis
You can purchase only the Executive Summary Middle East and Africa Market (2019 vs 2024 vs 2031)
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2019 -2031
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Nasal Decolonization market
Chapter 12 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Why Nasal Mupirocin have a significant impact on Nasal Decolonization market? |
What are the key factors affecting the Nasal Mupirocin and Nasal Povidone Iodine of Nasal Decolonization Market? |
What is the CAGR/Growth Rate of Hospital during the forecast period? |
By type, which segment accounted for largest share of the global Nasal Decolonization Market? |
Which region is expected to dominate the global Nasal Decolonization Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|
Published Report Editions
are Just a Tip of an Iceberg
Access the Complete Database of
Nasal Decolonization Market
Request Sample